Medable Partners with Seqster to Integrate RWD into Decentralized Trials
Medable Inc. has announced a new partnership with Seqster to integrate real-time, real-world data streams into decentralized clinical trials in efforts to improve trial recruitment and participation.
“Patients want clinical trials to fit into their real-world experience, not the other way around,” said Dr. Michelle Longmire, CEO and co-founder of Medable. “Working with Seqster, we can integrate data sources and data streams to provide clinicians with a more holistic view of patient health.”
Medable and Seqster are also partnering with Datavant to integrate and link de-identified data across the entire patient journey, including electronic health records, claims, and diagnostics, as well as emerging sources such as genomics, wearable devices, socioeconomic and behavioral data and more.
